BF Biosciences Limited (PSX:BFBIO)

BF Biosciences Statistics

Total Valuation

BF Biosciences has a market cap or net worth of PKR 13.58 billion. The enterprise value is 13.75 billion.

Market Cap	13.58B
Enterprise Value	13.75B

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

BF Biosciences has 88.33 million shares outstanding. The number of shares has increased by 37.69% in one year.

Current Share Class	88.33M
Shares Outstanding	88.33M
Shares Change (YoY)	+37.69%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.59%
Float	25.00M

Valuation Ratios

The trailing PE ratio is 27.28.

PE Ratio	27.28
Forward PE	n/a
PS Ratio	1.97
PB Ratio	2.82
P/TBV Ratio	2.82
P/FCF Ratio	n/a
P/OCF Ratio	46.66
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.03, with an EV/FCF ratio of -2,529.90.

EV / Earnings	27.98
EV / Sales	2.00
EV / EBITDA	13.03
EV / EBIT	16.94
EV / FCF	-2,529.90

Financial Position

The company has a current ratio of 2.15, with a Debt / Equity ratio of 0.37.

Current Ratio	2.15
Quick Ratio	1.08
Debt / Equity	0.37
Debt / EBITDA	1.71
Debt / FCF	-332.43
Interest Coverage	7.60

Financial Efficiency

Return on equity (ROE) is 13.47% and return on invested capital (ROIC) is 8.93%.

Return on Equity (ROE)	13.47%
Return on Assets (ROA)	6.00%
Return on Invested Capital (ROIC)	8.93%
Return on Capital Employed (ROCE)	12.15%
Revenue Per Employee	12.87M
Profits Per Employee	918,497
Employee Count	535
Asset Turnover	0.81
Inventory Turnover	2.82

Taxes

In the past 12 months, BF Biosciences has paid 318.15 million in taxes.

Income Tax	318.15M
Effective Tax Rate	39.30%

Stock Price Statistics

The stock price has increased by +3.23% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+3.23%
50-Day Moving Average	156.05
200-Day Moving Average	165.63
Relative Strength Index (RSI)	48.22
Average Volume (20 Days)	266,546

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BF Biosciences had revenue of PKR 6.88 billion and earned 491.40 million in profits. Earnings per share was 5.64.

Revenue	6.88B
Gross Profit	2.76B
Operating Income	811.73M
Pretax Income	809.55M
Net Income	491.40M
EBITDA	1.06B
EBIT	811.73M
Earnings Per Share (EPS)	5.64

Balance Sheet

The company has 1.64 billion in cash and 1.81 billion in debt, giving a net cash position of -169.83 million or -1.92 per share.

Cash & Cash Equivalents	1.64B
Total Debt	1.81B
Net Cash	-169.83M
Net Cash Per Share	-1.92
Equity (Book Value)	4.82B
Book Value Per Share	54.58
Working Capital	2.36B

Cash Flow

In the last 12 months, operating cash flow was 291.08 million and capital expenditures -296.52 million, giving a free cash flow of -5.44 million.

Operating Cash Flow	291.08M
Capital Expenditures	-296.52M
Free Cash Flow	-5.44M
FCF Per Share	-0.06

Margins

Gross margin is 40.08%, with operating and profit margins of 11.79% and 7.14%.

Gross Margin	40.08%
Operating Margin	11.79%
Pretax Margin	11.76%
Profit Margin	7.14%
EBITDA Margin	15.33%
EBIT Margin	11.79%
FCF Margin	n/a

Dividends & Yields

BF Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.69%
Shareholder Yield	-37.69%
Earnings Yield	3.62%
FCF Yield	-0.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BF Biosciences has an Altman Z-Score of 4.2 and a Piotroski F-Score of 5.

Altman Z-Score	4.2
Piotroski F-Score	5